Scandinibsa 3% - Inibsa

Local anaesthetic of weak vasodilator activity indicated for risk patients. Its use is recommended in dental procedures that require time and intermediate anaesthetic depth of the dental pulp.

Indications

Indicated for patients in which low concentration of anaesthetic in the plasma is advised (children, the elderly, etc.). SCANDINIBSA 30 mg/ml is indicated for local dental anaesthesia (by infiltration and nerve blockade) in adults and children aged 4 years or older.

Duration

Onset on action: 1-2 minutes
Pulpal anaesthesia: 20-40 minutes
Soft tissue: 120-180 minutes

Composition

1 ml of solution for injection contains:
Mepivacaine hydrochloride 30.0 mg
Methyl para-hydroxybenzoate (E-218) 0.6 mg

Presentations